AT265516B - Verfahren zur Herstellung von neuen N-Methylderivaten von Neomycinen, Kanamycinen und Paromomycinen - Google Patents
Verfahren zur Herstellung von neuen N-Methylderivaten von Neomycinen, Kanamycinen und ParomomycinenInfo
- Publication number
- AT265516B AT265516B AT959865A AT959865A AT265516B AT 265516 B AT265516 B AT 265516B AT 959865 A AT959865 A AT 959865A AT 959865 A AT959865 A AT 959865A AT 265516 B AT265516 B AT 265516B
- Authority
- AT
- Austria
- Prior art keywords
- sep
- formaldehyde
- paromomycins
- neomycins
- kanamycins
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 229930193140 Neomycin Natural products 0.000 title description 4
- 229930027917 kanamycin Natural products 0.000 title description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 45
- 230000003115 biocidal effect Effects 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 230000002829 reductive effect Effects 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000908 ammonium hydroxide Substances 0.000 description 5
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229940053050 neomycin sulfate Drugs 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 3
- HOIBDEYNUQFWNT-FFZMKEETSA-N neamine sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](N)C[C@@H]1N HOIBDEYNUQFWNT-FFZMKEETSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- CFUQBFQTFMOZBK-QUCCMNQESA-N ibazocine Chemical class C12=CC(O)=CC=C2C[C@H]2N(CC=C(C)C)CC[C@]1(C)C2(C)C CFUQBFQTFMOZBK-QUCCMNQESA-N 0.000 description 2
- 229960002064 kanamycin sulfate Drugs 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 125000001302 tertiary amino group Chemical group 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229960005065 paromomycin sulfate Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
- C07H15/232—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4378564A GB1055616A (en) | 1962-04-03 | 1964-10-27 | N-methylated derivatives of basic antibiotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT265516B true AT265516B (de) | 1968-10-10 |
Family
ID=10430298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT959865A AT265516B (de) | 1964-10-27 | 1965-10-22 | Verfahren zur Herstellung von neuen N-Methylderivaten von Neomycinen, Kanamycinen und Paromomycinen |
Country Status (3)
| Country | Link |
|---|---|
| AT (1) | AT265516B (enExample) |
| NO (1) | NO117363B (enExample) |
| SE (1) | SE324858B (enExample) |
-
1965
- 1965-10-06 NO NO159978A patent/NO117363B/no unknown
- 1965-10-11 SE SE13141/65A patent/SE324858B/xx unknown
- 1965-10-22 AT AT959865A patent/AT265516B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| NO117363B (enExample) | 1969-08-04 |
| SE324858B (enExample) | 1970-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2515629A1 (de) | Paromomycin-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| AT265516B (de) | Verfahren zur Herstellung von neuen N-Methylderivaten von Neomycinen, Kanamycinen und Paromomycinen | |
| DE3302699A1 (de) | N-methansulfonsaeure-derivate von 3-0-demethylistamycin b und verfahren zu ihrer herstellung | |
| DE1468937A1 (de) | Verfahren zur Herstellung von Derivaten von Antibiotica | |
| EP0027209B1 (de) | N,N-Dimethyl-N'-isobutyl-N'-Beta-hydroxyethyl-1,3-propylendiamin und Verfahren zu seiner Herstellung | |
| DE478948C (de) | Verfahren zur Herstellung von Kondensationsprodukten aus Aldehyden und Aminen | |
| DE550121C (de) | Verfahren zur Herstellung von Formaldehyd | |
| DE833818C (de) | Verfahren zur Herstellung von neuen mono- und diquartaeren Salzen von Pyrimidylaminocinnolinen | |
| DE69605520T2 (de) | Natrium-Orthohydroxymandelat-Phenol-Wasser-Komplexe, Verfahren zu deren Herstellung sowie Verwendung zur Isolation des Natrium Orthohydroxymandelats | |
| AT214079B (de) | Verfahren zur Herstellung eines N-Glycosides von 5-Fluor-uracil | |
| DE1518608C3 (de) | Verfahren zur Herstellung von N-PhenyW-alkoxy-NP-alkyl-harnstoffen | |
| AT134999B (enExample) | ||
| DE1155138B (de) | Verfahren zur Herstellung unsymmetrisch disubstituierter Hydrazine | |
| AT228191B (de) | Verfahren zur Herstellung von neuen Arylglucosaminiden | |
| DE2019176C3 (de) | Verfahren zur Herstellung von Alkylcoba la minen | |
| DE69300691T2 (de) | Verfahren zur Herstellung von Etoposidphosphat und Zwischenprodukte davon. | |
| AT263209B (de) | Verfahren zur Herstellung von neuen 6-Desoxytetracyclinderivaten | |
| DE703897C (de) | Verfahren zur Herstellung von basischem Methylquecksilbernitrat | |
| DE737543C (de) | Weichmacher | |
| AT226713B (de) | Verfahren zur Herstellung von neuen Piperazinderivaten | |
| DE744756C (de) | Verfahren zur Herstellung von 6-Isoamylamino-2-methylheptan | |
| DE820004C (de) | Verfahren zur Herstellung von Loesungen von Sulfonamiden | |
| AT265236B (de) | Verfahren zur Herstellung von Aminomethylenmalononitril | |
| DE936334C (de) | Verfahren zur Herstellung als Arzneimittel verwendbarer Aldehydderivate | |
| DE946982C (de) | Verfahren zur Herstellung von kristallisiertem Aluminiumformiat |